flâneur

Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform - PMC

ncbi.nlm.nih.gov · 5,327 words · saved by 1 readers

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. Innovation — the discovery of ways to get more value from limited resources — is critically important for both society’s health and material standard of living. A widely held view is that there would be too little innovation without government support.1 This view is common in the drug discovery sector, which has faced declining productivity and mounting costs over the last three decades.2 Governments support drug discovery and development in several ways,

Innovation — the discovery of ways to get more value from limited resources — is critically important for both society’s health and material standard of living. A widely held view is that there would be too little innovation without government support.1 This view is common in the drug discovery sector, which has faced declining productivity and mounting costs over the last three decades.2 Governments support drug discovery and development in several ways, including direct and indirect subsidies of basic research, clinical trials and other costs associated with research and development. The…

related reading